CommCare as a Tool to Reduce Loss to Follow Up

Slides:



Advertisements
Similar presentations
Antiretroviral Therapy Standard Core Indicators. Emergency Plan for AIDS Relief 2 million people reached with ART 7 million new infects prevented 10 million.
Advertisements

TB/HIV Integration What it entails Frank Lule, Eyerusalem Negussie, Reuben Granich, Haileyesus Getahun.
"3 by 5" progress December 2005 Progress on global access to HIV antiretroviral therapy | 12 April |2 | Antiretroviral therapy coverage in low-
Absorption, Retention and Empowerment
Washington D.C., USA, July 2012www.aids2012.org A National Program Manager’s Perspective on HIV/TB Integration Dr Owen Mugurungi Director – AIDS.
Monitoring and Evaluation Frameworks   What is an M&E Framework?   Why do we use M&E Frameworks?   How do we develop M&E Frameworks? MEASURE Evaluation.
Dr. Yogan Pillay Deputy Director General National Department of Health, South Africa Monday 1 July 2013 OPERATIONAL AND PROGRAMMATIC CONSIDERATIONS IN.
Kevin Fenton, MD, PhD, FFPH Director, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Centers for Disease Control and Prevention.
Current international guidelines recommend 6–9 months of isoniazid (INH) preventive chemotherapy to prevent the development of active tuberculosis in.
Morbidity Monitoring Project Data for Resource Planning and Evaluation A.D. McNaghten Centers for Disease Control and Prevention.
Challenges of service integration: the TB model Linda-Gail Bekker The Desmond Tutu HIV Centre, Faculty of Health Sciences, University of Cape Town, South.
Moving from a commodity approach: “Fund some of everything” or “Fund what is comfortable” to An Investment approach: “Fund evidenced-based activities.
Using HIV Surveillance to Achieve High Impact Prevention Irene Hall, PhD, FACE AIDS 2012 High-Impact Prevention: Reducing the HIV Epidemic in the United.
Management and Development for Health (MDH)
ART for Prevention From Evidence to Action Wafaa El-Sadr, MD, MPH ICAP-Columbia University.
JORDAN E. LAKE, MD, MSC AAHU SEPTEMBER 2014 Prevention for Positives.
6 th Biannual Joint HIV Sector Review Meeting Nov 11-13,2014 Ministry of Health and Social Welfare Mwanaisha Nyamkara, NTLP Werner Maokola, NACP Nov 11,
Ministry of Health, Mozambique
ZIMBABWE AIDS CARE FOUNDATION NEWLANDS CLINIC Virological Outcomes in Adult Patients on Second Line ART, at Newlands Clinic Dr S. Bote.
Providing Treatment, Restoring Hope Program Updates Dr. Robb Sheneberger, MD University of Maryland School of Medicine Track 1.0 Implementers Meeting Dar.
Intervention Strategy in Improving ART Adherence In Tanzania Salama Mwakisu-MSH, Dr D Sando-NACP, Dr R. Malele-MUHAS, Bernard Rabiel- NACP, Dr G. Somi-NACP,
HIV/AIDS Track Session. Key Points Application of international reference price list during a national tender is a valuable tool for achieving optimal.
Maximizing Linkages to OVC Programs
Outcomes of Antiretroviral Treatment Programs in Rural Lesotho: Health Centers and Hospitals Compared Niklaus Labhardt, Motlalepula Sello, Mamokone A.
The investment framework - Critical enablers are not a luxury! Bernhard Schwartlander.
Scale up TB/HIV activities in Asia Pacific 8-9Aug09 1 TB/HIV collaborative activities in Thailand Sriprapa Nateniyom, M.D. TB Bureau, Department of Disease.
HIV Testing for TB Patients in the Context of ART Scale-Up - Barriers to Implementation Kevin M. De Cock, MD CDC Kenya Geneva, February 14, 2005.
HIV TESTING AND EXPANSION OF ART FOR TB PATIENTS, BOTTLE NECKS CHALLENGES AND ENABLERS FOR SCALE UP IN KENYA DR. JOSEPH SITIENEI, OGW NTP MANAGER - KENYA.
Sub module 3 Pre-ART and ART registers. Purpose of registers Key individual information for: Facilitating patient management by the identification of.
WAD SYMPOSIUM 2014 ART Adherence and Retention: MDH Experience Eric Aris Management and Development for Health 29 th November 2014 NJOMBE.
INVESTING IN COMMUNITY SYSTEMS TO SUPPORT LIFELONG ART INITIATED IN MATERNAL & CHILD HEALTH SETTINGS Dr. Chewe Luo MD, PhD, FRCP UNICEF PROGRAM DIVISION.
Improving Patients Retention in Antiretroviral Treatment Programs: The experience of ARV Programs in Côte d’Ivoire Eugène MESSOU, MD, PhD CePReF- Aconda.
Expert Patients and AIDS Ministry of HealthMSF-OCB Mozambique CDC From Field Operational Research to National Roll Out of CASG in Mozambique.
Every day. In times of crisis. For our future. Dr. Kechi Achebe, Senior Director HIV/AIDS & TB Integrated Community Case Management - One Opportunity for.
HIV-RH INTEGRATION IN TANZANIA
Priscilla Tsondai, Lynne Wilkinson, Anna Grimsrud, Angelina Trivino,
Index Partner Testing and Targeted Case Finding in Northern Haiti
Factors associated with loss to follow up in a primary healthcare clinic practicing test and treat Authors: Julius Kiwanuka1,2, Noah Kiwanuka3, Flavia.
Amir Shroufi Medical Coordinator MSF South Africa
How differentiated care supports “Tx all” and Dr
Example Mapping and Challenges Tanzania stakeholder meeting Nov 2016
Men are absent across the HIV continuum of care in a rural area of southern Mozambique Laura Fuente-Soro, Elisa Lopez-Varela, Orvalho Augusto , Charfudin.
TB/ HIV CONTROL AND MANAGEMENT IN SOUTH AFRICA
Number of people receiving antiretroviral therapy in
HIV and AIDS The management of HIV and AIDS is an ongoing challenge for Anglo companies operating in countries with a high burden of HIV disease Strategy.
Overview of Global HIV Epidemic
Carolyn M. Audet. ; Erin Graves; Magdalena Bravo; Muktar H
Continuum of HIV Care, Treatment, and Prevention
L.F. Jefferys1, J. Hector1, M.A. Hobbins2, J. Ehmer2, N. Anderegg3
Expanding ARV treatment in developing countries: Issues and Prospects
Background Results Methods Conclusion
Cross-sectional assessment of patient outcomes using a systematic file review process: Results from 12,987 patient files Ambereen Jaffer, Gesine Meyer-Rath,
Better Retention Rates Observed in Patients on Lopinavir than Atazanavir in Uganda
Utilizing research as an opportunity to strengthen
A COLLABORATIVE APPROACH TO ESTABLISH PREDICTORS
Monitoring the implementation of the TB Action Plan for the WHO European Region, 2016–2020 EU/EEA situation in 2016 ECDC Tuberculosis Programme European.
Tiffany G. Harris, PhD, MS Director of Strategic Information
Antiretroviral therapy coverage in sub-Saharan Africa,
Dorina Onoya1, Tembeka Sineke1, Alana Brennan1,2, Matt Fox1,2
Community patient tracking by Lay Community Health Workers (CHWs) is an effective strategy towards the 2nd & 3rd 90 Morapedi Boitumelo M.
Knowing your epidemic and knowing your response – maximising routinely collected data to measure and monitor HIV epidemics in sub-Saharan Africa Monitoring.
Estimated number of people living with HIV and adult HIV prevalence
Division of Global HIV & TB
Indian Scenario HIV Situation TB Situation
Retention: What It Means for You
Management and Development for Health (MDH)
Introduction to poster session and discussion
Share your thoughts on this presentation with #IAS2019
Prevalence of recent alcohol and substance use in persons with HIV and associations with HIV care cascade outcomes in South Africa Adrienne E Shapiro,
HUMAN IMMUNODEFICIENCY VIRUS (HIV) PREVENTION & CARE
Presentation transcript:

CommCare as a Tool to Reduce Loss to Follow Up Case Study: CDC Partners in Mozambique Jolani de la Porte Presented by:

Background Adherence to HIV and TB regimens is important to improve patient outcomes and prevent the spread of the disease In Mozambique HIV prevalence in adults between 15 - 49 years of age is 11.5% In Mozambique in 2014 retention in care is at 67% at 12-months and 52% after 36 months among HIV patients undergoing ART2 1Deeks SG, Gange SJ et al. Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America. Clin Infect Dis. 2009 Nov 15; 49(10):1582-90. 2 Fox MP, Rosen S. Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review. Trop Med Int Health. 2010 Jun; 15 Suppl 1():1-15.

Nationally Consolidated LTFU mHealth Toolkit for HIV/TB Mozambique

LTFU strategy Identified Contacted Referral Made Returned to Health Facility Completed 6 months

Problem Contacted Identified Referral Made Arrived at Health Facility Completed 6 months follow up

Solution: App Workflow + Identification Contact Referral Arrival Recuperation

Solution: Summary Tools

Solution: Drill-down reports Identified Contacted Referral Made Arrived at Health Facility Completed 6 months follow up

Solution: Drill-down Reports Referrals Made Name Type of Referral Days Open CHW Responsible

Solution: Drill down Reports Name Days Open Defaults Emailed Reports Mobile Reporting CHWs or Supervisors Web Reports

Summary Strengthen LTFU process through: Improved patient tracking and two way communication between community and clinic levels Timely supervision and follow up on patients who are at risk of dropping out at each step of the LTFU process through actionable reports Improved quality of home visits and adherence counselling Provide better insights into reasons patients are dropping out for more targeted interventions Support scale-up of LTFU strategy through nationally consolidated LTFU toolkit

Download Application from CommCare Exchange Ali, any outcomes/conclusions worth mentioning? https://www.commcarehq.org/exchange/59cc05b652dfcaec152760b7eec7bbf3/info/